Results 161 to 170 of about 3,355 (200)

Case Report: Kawasaki disease associated with acute generalized exanthematous pustulosis secondary to carbocysteine. [PDF]

Front Pediatr
Furuta T, Fukumoto H, Fujiwara M, Fukunaga S, Ishikawa Y, Hirano R.   +5 more
europepmc   +1 more source

Acute generalized exanthematous pustulosis associated with spider bite [PDF]

Aline Barcellos Grill, Cardoso JLC, Carlos Augusto Mello-da-Silva, Davidovici BB, Deise Louise Bohn Rhoden, Fernando SL, Gerson Vettorato, Giana Paula Müller, Lane L, Laura de Mattos Milman, Leclair MA, Makris M, Malaque CM, Paulo Ricardo Martins Souza, Razera F, Robb CW, Sidoroff A   +16 more
core   +1 more source

Acute generalized exanthematous pustulosis following ceftriaxone.

Indian J Pharmacol
Shah MM, Dhanani S, Patel K, Nair P.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Acute Generalized Exanthematous Pustulosis

JAMA Dermatology, 2021
Acute generalized exanthematous pustulosis (AGEP) is an acute, self-limited, widespread cutaneous eruption characterized by the development of numerous, non-follicular, sterile pustules on a background of erythematous, edematous skin. The eruption usually develops within hours to days of exposure to medications (antibiotics, antifungals, calcium ...
Jinwoo, Lee, Alyson, Endicott, Kanade, Shinkai   +2 more
openaire   +3 more sources

Acute generalized exanthematous pustulosis

Australasian Journal of Dermatology, 1995
SUMMARYA case of acute generalized exanthematous pustulosis (AGEP) is described. A brief review of AGEP is undertaken with emphasis on its differentiation from acute generalized pustular psoriasis. AGEP is also compared with and contrasted to acute febrile neutrophilic dermatosis, or ‘Sweet's syndrome’ and Sneddon‐Wilkinson pustular dermatosis.
S, Lee, P, Artemi, D, Holt
  +5 more sources

Acute generalized exanthematous pustulosis

Journal of the American Academy of Dermatology, 2011
Acute generalized exanthematous pustulosis is a cutaneous reaction pattern typically precipitated by medication exposure. It has an estimated incidence of 1 to 5 cases per million per year and can occur in all age groups. Diagnosis is based on typical rash morphology, histopathology, and clinical course.
Jennifer L, Pecina, Mark A, Cappel
  +6 more sources

Acute generalized exanthematous pustulosis

Seminars in Cutaneous Medicine and Surgery, 1996
Acute generalized exanthematous pustulosis (AGEP) is now a well-known clinical entity, characterized by acute onset with associated fever, and numerous non-follicular pin-head sterile pustules on erythematous background. The biopsy evidences subcorneal pustules resembling those of pustular psoriasis. However, polymorphic aspects such as pseudo-erythema
C, Beylot, M S, Doutre, M, Beylot-Barry
openaire   +2 more sources

Acute Generalized Exanthematous Pustulosis

Current Opinion in Allergy & Clinical Immunology, 2009
The purpose of the present review is to update knowledge on acute generalized exanthematous pustulosis (AGEP) in terms of epidemiology, pathogenesis, cause, clinical features, diagnosis, and treatment.AGEP is a rare reaction pattern attributed mainly to drugs.
openaire   +5 more sources

Acute Generalized Exanthematous Pustulosis

2018
Acute generalized exanthematous pustulosis (AGEP) is a rapidly progressing erythroderma with studded pustules which typically occurs within 24–48 h of medication exposure and resolves quickly with its cessation.
Aysha Javed, Ian H. Coulson
  +4 more sources